Showing results (341-350 of 454) with videos related to

Sort By:
Pageof 46
Liver International : Official Journal of the International Association for the Study of the Liver|October 4, 2014
Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log10 copies/ml)Scott Fung, Stuart C Gordon, Zahary Krastev, et al.
Scientific Reports|July 21, 2019
Large-scale viral genome analysis identifies novel clinical associations between hepatitis B virus and chronically infected patientsOndrej Podlaha, Edward Gane, Maurizia Brunetto, et al.
Antimicrobial Agents and Chemotherapy|July 25, 2018
No Resistance to Tenofovir Alafenamide Detected through 96 Weeks of Treatment in Patients with Chronic Hepatitis B InfectionAndrea L Cathcart, Henry Lik-Yuen Chan, Neeru Bhardwaj, et al.
Scientific Reports|December 18, 2021
Late presentation of chronic HBV and HCV patients seeking first time specialist care in Spain: a 2-year registry reviewCamila A Picchio, Sabela Lens, Manuel Hernandez-Guerra, et al.
Alimentary Pharmacology & Therapeutics|November 25, 2022
Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg-positive chronic hepatitis BJosef Wagner, Lilly Yuen, Margaret Littlejohn, et al.
Alimentary Pharmacology & Therapeutics|January 19, 2021
Incremental value of HBcrAg to classify 1582 HBeAg-negative individuals in chronic infection without liver disease or hepatitisMaurizia R Brunetto, Ivana Carey, Benjamin Maasoumy, et al.
Hepatology (Baltimore, Md.)|January 22, 2011
Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver diseaseYun-Fan Liaw, I-Shyan Sheen, Chuan-Mo Lee, et al.
Antimicrobial Agents and Chemotherapy|December 17, 2014
Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in treatment-naive patients with chronic hepatitis C virus infection and advanced liver fibrosis or cirrhosisStefan Zeuzem, Vicente Soriano, Tarik Asselah, et al.
Alimentary Pharmacology & Therapeutics|September 4, 2020
Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosisMilan J Sonneveld, Willem P Brouwer, Bettina E Hansen, et al.
Annals of Hepatology|October 4, 2025
A multinational survey of physician knowledge about management of chronic hepatitis CMohamed El-Kassas, Yusuf Yilmaz, Chun-Jen Liu, et al.
Pageof 46